The Innovative Vector Control Consortium: improved control of mosquito-borne diseases.
Few new insecticides have been produced for control of disease vectors for public health in developing countries over the past three decades, owing to market constraints, and the available insecticides are often poorly deployed. The Innovative Vector Control Consortium will address these market failures by developing a portfolio of chemical and technological tools that will be directly and immediately accessible to populations in the developing world. The Bill and Melinda Gates Foundation has supported this new initiative to enable industry and academia to change the vector control paradigm for malaria and dengue and to ensure that vector control, alongside drugs, case management and vaccines, can be better used to reduce disease.
Hemingway
Janet
J
Liverpool School of Tropical Medicine, Pembroke Place, Liverpool, UK, L3 5QA. hemingway@liv.ac.uk
Beaty
Barry J
BJ
Rowland
Mark
M
Scott
Thomas W
TW
Sharp
Brian L
BL
D000818:Animals; D014355:Chagas Disease / Q000517:prevention & control; D009033:Culicidae; D003661:Decision Support Techniques; D003715:Dengue / Q000517:prevention & control; D003906:Developing Countries; D005368:Filariasis / Q000517:prevention & control; D014943:Global Health; D006801:Humans; D007300:Insect Control / Q000191:economics* / Q000379:methods* / Q000592:standards; D007303:Insect Vectors; D007306:Insecticides / Q000191:economics; D007896:Leishmaniasis / Q000517:prevention & control; D008288:Malaria / Q000517:prevention & control
D007306:Insecticides